Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID	DTD0081 Transporter Info
Gene Name	SLC11A2
Transporter Name	Natural resistance-associated macrophage protein 2
Gene ID	4891
UniProt ID	P49281

Microbiota Influence of This DT (MBI)

Bacteria: Actinomycetota
Genus: Corynebacterium
Corynebacterium diphtheriae	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[1] , [2] , [3] , [4]
Regulating Factor	Corynebactin
Detailed Description	The compound Corynebactin Secreted by Corynebacterium diphtheriae C7 (beta) has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [8]
Regulating Factor	MntABCD , , ,
Detailed Description	The protein MntABCD of Corynebacterium diphtheriae C7 (beta) has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Mycobacterium
Mycobacterium avium	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [10] , [11] , [12]
Regulating Factor	Mycobactin
Studied Tissue	Blood
In Vivo Model	C57BL/6 mice
Detailed Description	The compound mycobactin secreted by Mycobacterium avium 101 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [3] , [4]
Regulating Factor	Carboxymycobactin
Detailed Description	The compound Carboxymycobactin Secreted by Mycobacterium avium CRl/69 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Mycobacterium tuberculosis	Microbe Info	Click to Show/Hide the Full List 11 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [10] , [11] , [12]
Regulating Factor	Mycobactin
Studied Tissue	Blood
In Vivo Model	C57BL/6 mice
Detailed Description	The compound Mycobactin Secreted by Mycobacterium tuberculosis H37Rv has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [9] , [14]
Regulating Factor	Desferriexochelin 772MS
Detailed Description	The compound Desferriexochelin 772MS Secreted by Mycobacterium tuberculosis str. Erdman has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[11] , [12] , [15] , [16]
Regulating Factor	Mycobactin
Detailed Description	The compound mycobactin secreted by Mycobacterium tuberculosis has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [3] , [4]
Regulating Factor	desA1
Detailed Description	The protein desA1 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [3] , [4]
Regulating Factor	GAPDH
Detailed Description	The protein GAPDH of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 6	Co-transport of human SLC11A2 substrates/drugs in the health condition		[9] , [17] , [4]
Regulating Factor	IrtAB ,
Detailed Description	The protein IrtAB of Mycobacterium tuberculosis H37Rv has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 7	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [11] , [12] , [18]
Regulating Factor	mntH
Detailed Description	The protein mntH of Mycobacterium tuberculosis H37Rv has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 8	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [3] , [4]
Regulating Factor	Rv0641
Detailed Description	The protein Rv0641 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 9	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [3] , [4]
Regulating Factor	Rv0704
Detailed Description	The protein Rv0704 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 10	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [3] , [4]
Regulating Factor	Rv1872c
Detailed Description	The protein Rv1872c of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 11	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [3] , [4]
Regulating Factor	tuf
Detailed Description	The protein tuf of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Mycolicibacterium
Mycolicibacterium smegmatis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [10] , [11] , [12]
Regulating Factor	Mycobactin
Studied Tissue	Blood
In Vivo Model	C57BL/6 mice
Detailed Description	The compound Mycobactin Secreted by Mycolicibacterium smegmatis MC2 155 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Mycolicibacterium vaccae	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [19] , [3] , [4]
Regulating Factor	Exochelin 772SM
Detailed Description	The compound Exochelin 772SM Secreted by Mycolicibacterium vaccae R877R has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Bacteria: Bacillota
Genus: Bacillus
Bacillus anthracis	Microbe Info	Click to Show/Hide the Full List 4 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [20] , [21] , [22]
Regulating Factor	Corynebactin
Detailed Description	The compound Corynebactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [20] , [21] , [22]
Regulating Factor	Petrobactin
Detailed Description	The compound Petrobactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[23] , [24] , [3] , [4]
Regulating Factor	Petrobactin
Detailed Description	The compound Petrobactin Secreted by Bacillus anthracis str. Sterne has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[4] , [5] , [6] , [7] , [25]
Regulating Factor	mntA
Studied Tissue	Blood
In Vivo Model	ICR mice
Detailed Description	The protein mntA of Bacillus anthracis str. Vollum has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Bacillus cereus	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [20] , [21] , [22]
Regulating Factor	Corynebactin
Detailed Description	The compound Corynebactin Secreted by Bacillus cereus ATCC 14579 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [20] , [21] , [22]
Regulating Factor	Petrobactin
Detailed Description	The compound Petrobactin Secreted by Bacillus cereus ATCC 14579 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Bacillus thuringiensis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [20] , [21] , [22]
Regulating Factor	Corynebactin
Detailed Description	The compound Corynebactin Secreted by Bacillus thuringiensis ATCC 33679 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Enterococcus
Enterococcus faecalis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [26]
Regulating Factor	efaA
Detailed Description	The protein efaA of Enterococcus faecalis JH2-2 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Lactiplantibacillus
Lactiplantibacillus plantarum	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[4] , [5] , [6] , [7] , [27]
Regulating Factor	mntA
Detailed Description	The protein mntA of Lactiplantibacillus plantarum subsp. plantarum ATCC 14917 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Limosilactobacillus
Limosilactobacillus reuteri	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Down regulating of SLC11A2 expression in conventional mice compared with germ-free mice		[28] , [29]
Regulating Factor	1,3-Diaminopropane
Regulation Mechanism	via suppression of Endothelial PAS domain-containing protein 1 (EPAS1)		Transcription Factor Info
Studied Phenotype	Conventional mice compared with germ-free mice [ICD11: N.A]
Studied Tissue	Duodenum
In Vivo Model	C57BL/6 germ-free mice
In Vitro Model	Human colon carcinoma cells (HCT-116)
Detailed Description	The compound 1,3-Diaminopropane Generated by Limosilactobacillus reuteri MM4-1A has been reported to decrease the expression of the drug transporter SLC11A2.
Microbe Influence 2	Down regulating of SLC11A2 expression in conventional mice compared with germ-free mice		[28] , [29]
Regulating Factor	3-Hydroxypropanal
Regulation Mechanism	via suppression of Endothelial PAS domain-containing protein 1 (EPAS1)		Transcription Factor Info
Studied Phenotype	Conventional mice compared with germ-free mice [ICD11: N.A]
Studied Tissue	Duodenum
In Vivo Model	C57BL/6 germ-free mice
In Vitro Model	Human colon carcinoma cells (HCT-116)
Detailed Description	The compound 3-Hydroxypropanal Generated by Limosilactobacillus reuteri MM4-1A has been reported to decrease the expression of the drug transporter SLC11A2.
Genus: Staphylococcus
Staphylococcus aureus	Microbe Info	Click to Show/Hide the Full List 17 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [30] , [3] , [4]
Regulating Factor	Aureochelin
Detailed Description	The compound aureochelin secreted by Staphylococcus aureus has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [31] , [3] , [4]
Regulating Factor	Staphyloferrin A
Detailed Description	The compound Staphyloferrin A Secreted by Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[1] , [32] , [3] , [4]
Regulating Factor	Staphylopine
Detailed Description	The compound Staphylopine Secreted by Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [33]
Regulating Factor	MntABC , ,
Studied Tissue	Liver
In Vivo Model	C57BL/6 mice
Detailed Description	The protein MntABC of Staphylococcus aureus subsp. aureus str. Newman has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 5	Co-transport of human SLC11A2 substrates/drugs in the health condition		[34] , [35] , [4]
Regulating Factor	FhuCBG , ,
Detailed Description	The protein FhuCBG of Staphylococcus aureus RN6390 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 6	Sequestration of human SLC11A2 substrates/drugs in the health condition		[34] , [35] , [4]
Regulating Factor	fhuD1
Detailed Description	The protein fhuD1 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 7	Sequestration of human SLC11A2 substrates/drugs in the health condition		[34] , [35] , [4]
Regulating Factor	fhud2
Detailed Description	The protein fhud2 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 8	Sequestration of human SLC11A2 substrates/drugs in the health condition		[1] , [36] , [4]
Regulating Factor	fhud2
Detailed Description	The protein fhud2 of Staphylococcus aureus RN2564 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 9	Co-transport of human SLC11A2 substrates/drugs in the health condition		[34] , [37] , [3] , [4]
Regulating Factor	HtsABC , ,
Detailed Description	The protein HtsABC of Staphylococcus aureus RN6390 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 10	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [38] , [3] , [4]
Regulating Factor	isdA
Detailed Description	The protein isdA of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 11	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [39] , [3] , [4]
Regulating Factor	isdA
Detailed Description	The protein isdA of Staphylococcus aureus BB has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 12	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [40] , [3] , [4]
Regulating Factor	isdA
Detailed Description	The protein isdA of Staphylococcus aureus N100 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 13	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [41] , [4]
Regulating Factor	MntABC , ,
Detailed Description	The protein MntABC of Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 14	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [41]
Regulating Factor	MntABC , ,
Detailed Description	The protein MntABC of Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 15	Sequestration of human SLC11A2 substrates/drugs in the health condition		[34] , [37] , [3] , [4]
Regulating Factor	SfaABC , ,
Detailed Description	The protein SfaABC of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 16	Co-transport of human SLC11A2 substrates/drugs in the health condition		[34] , [42] , [3] , [4]
Regulating Factor	SirABC , ,
Detailed Description	The protein SirABC of Staphylococcus aureus subsp. aureus RN4220 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 17	Co-transport of human SLC11A2 substrates/drugs in the health condition		[34] , [43] , [3] , [4]
Regulating Factor	SstABCD , , ,
Detailed Description	The protein SstABCD of Staphylococcus aureus W has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Staphylococcus capitis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [44]
Regulating Factor	scaDMT
Detailed Description	The protein scaDMT of Staphylococcus capitis DSM 20326 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Staphylococcus epidermidis	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[9] , [39] , [3] , [4]
Regulating Factor	Tpn
Detailed Description	The protein tpn of Staphylococcus epidermidis 138 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [40] , [3] , [4]
Regulating Factor	Tpn
Detailed Description	The protein tpn of Staphylococcus epidermidis 2 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Streptococcus
Streptococcus agalactiae	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [45] , [4]
Regulating Factor	FhuCDB , ,
Detailed Description	The protein FhuCDB of Streptococcus agalactiae A909 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Streptococcus equi	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in upper and lower airway disease condition		[46] , [47] , [4]
Regulating Factor	mtsB
Studied Phenotype	Upper and lower airway disease [ICD11: CA22]
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein mtsB of Streptococcus equi subsp. equi NCTC 9682 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[46] , [47] , [4]
Regulating Factor	mtsB
Detailed Description	The protein mtsB of Streptococcus equi subsp. zooepidemicus NCTC 7023T has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Streptococcus gordonii	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [48]
Regulating Factor	AdcRCBA , , ,
Detailed Description	The protein AdcRCBA of Streptococcus gordonii str. Challis has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 2	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [49]
Regulating Factor	ScaCBA , ,
Detailed Description	The protein ScaCBA of Streptococcus gordonii str. Challis substr. CH1 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Streptococcus mutans	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in endocarditis condition		[5] , [6] , [7] , [50]
Regulating Factor	SloABC , ,
Studied Phenotype	Endocarditis [ICD11: 1B41.1]
Studied Tissue	Heart
In Vivo Model	Endocarditis rats
Detailed Description	The protein SloABC of Streptococcus mutans V403 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Streptococcus parasanguinis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [51]
Regulating Factor	fimA
Detailed Description	The protein fimA of Streptococcus parasanguinis FW213 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Streptococcus pneumoniae	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [6] , [7] , [52]
Regulating Factor	psaA
Detailed Description	The protein psaA of Streptococcus pneumoniae D39 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [53]
Regulating Factor	PsaABC , ,
Detailed Description	The protein PsaABC of Streptococcus pneumoniae D39 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Streptococcus pyogenes	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in bacterial pneumonia condition		[5] , [6] , [7] , [54]
Regulating Factor	MtsABC , ,
Studied Phenotype	Bacterial pneumonia [ICD11: A40.0]
Studied Tissue	Lung
In Vivo Model	BALB/c mice
Detailed Description	The protein MtsABC of Streptococcus pyogenes AP1 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Streptococcus suis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in sepsis condition		[5] , [55] , [4]
Regulating Factor	troA
Studied Phenotype	Sepsis [ICD11: 1G40-1G41]
Studied Tissue	Liver
In Vivo Model	CD-1 mice
Detailed Description	The protein troA of Streptococcus suis serotype 9 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Bacteria: Campylobacterota
Genus: Campylobacter
Campylobacter coli	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [56] , [57] , [58]
Regulating Factor	cfrB
Detailed Description	The protein cfrB of Campylobacter coli W13A has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Campylobacter jejuni	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [56] , [57] , [59]
Regulating Factor	cfrA
Detailed Description	The protein cfrA of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [56] , [57] , [58]
Regulating Factor	cfrB
Detailed Description	The protein cfrB of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [56] , [57] , [60]
Regulating Factor	ctuA
Detailed Description	The protein ctuA of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Co-transport of human SLC11A2 substrates/drugs in the health condition		[56] , [57] , [61] , [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[56] , [62] , [4]
Regulating Factor	p19
Detailed Description	The protein p19 of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Bacteria: Cyanobacteriota
Genus: Synechocystis
Synechocystis sp. PCC 6803	Microbe Info	Click to Show/Hide the Full List 4 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[63] , [64] , [4]
Regulating Factor	futA1
Detailed Description	The protein futa1 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[63] , [64] , [4]
Regulating Factor	futA2
Detailed Description	The protein futa2 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[63] , [64] , [4]
Regulating Factor	futB
Detailed Description	The protein futb of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[63] , [65] , [4]
Regulating Factor	sll1878
Detailed Description	The protein sll1878 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Bacteria: Pseudomonadota
Genus: Achromobacter
Achromobacter xylosoxidans	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [3] , [4]
Regulating Factor	Alcaligin
Detailed Description	The compound Alcaligin Secreted by Achromobacter xylosoxidans subsp. xylosoxydans KN 3-1 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Acinetobacter
Acinetobacter baumannii	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[66] , [3] , [4]
Regulating Factor	tonB3
Detailed Description	The protein tonB3 of Acinetobacter baumannii ATCC 19606 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Bordetella
Bordetella bronchiseptica	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [67] , [3] , [4]
Regulating Factor	Alcaligin
Detailed Description	The compound Alcaligin Secreted by Bordetella bronchiseptica B013N has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Bordetella pertussis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [67] , [3] , [4]
Regulating Factor	Alcaligin
Detailed Description	The compound Alcaligin Secreted by Bordetella pertussis UT25 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Bradyrhizobium
Bradyrhizobium diazoefficiens	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [68] , [4]
Regulating Factor	mnoP
Detailed Description	The protein mnoP of Bradyrhizobium diazoefficiens USDA 110 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Burkholderia
Burkholderia cepacia	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [69] , [3] , [4]
Regulating Factor	Cepabactin
Detailed Description	The compound Cepabactin Secreted by Burkholderia cepacia ATCC 25416 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [70] , [3] , [4]
Regulating Factor	Ornibactin
Detailed Description	The compound Ornibactin Secreted by Burkholderia cepacia TVV69 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [71] , [3] , [4]
Regulating Factor	Salicylic acid
Detailed Description	The compound Salicylic acid Secreted by Burkholderia cepacia Pc275c has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Escherichia
Escherichia coli	Microbe Info	Click to Show/Hide the Full List 18 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [72] , [3] , [4]
Regulating Factor	Aerobactin
Detailed Description	The compound Aerobactin Secreted by Escherichia coli LG1315 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[73] , [3] , [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Escherichia coli BW25113 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [72] , [3] , [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Escherichia coli str. K-12 substr. W3110 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [74] , [3] , [4]
Regulating Factor	Enterobactin
Detailed Description	The compound enterobactin secreted by Escherichia coli 9.0111 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [75] , [3] , [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Escherichia coli AB33II has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 6	Sequestration of human SLC11A2 substrates/drugs in the health condition		[63] , [76] , [3] , [4]
Regulating Factor	efeO
Detailed Description	The protein efeO of Escherichia coli Nissle 1917 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 7	Co-transport of human SLC11A2 substrates/drugs in the health condition		[63] , [77] , [4]
Regulating Factor	efeU
Detailed Description	The protein efeU of Escherichia coli O157:H7 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 8	Co-transport of human SLC11A2 substrates/drugs in the health condition		[63] , [76] , [4]
Regulating Factor	efeU
Detailed Description	The protein efeU of Escherichia coli Nissle 1917 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 9	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [78] , [4]
Regulating Factor	fecA
Detailed Description	The protein fecA of Escherichia coli UT5600 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 10	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [79] , [4]
Regulating Factor	feoA
Detailed Description	The protein feoA of Escherichia coli str. K-12 substr. MC4100 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 11	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [79] , [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Escherichia coli str. K-12 substr. MC4100 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 12	Co-transport of human SLC11A2 substrates/drugs in the health condition		[80] , [81] , [4]
Regulating Factor	fhuA
Detailed Description	The protein fhuA of Escherichia coli K-12 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 13	Co-transport of human SLC11A2 substrates/drugs in the health condition		[80] , [82] , [4]
Regulating Factor	fhuB
Detailed Description	The protein fhuB of Escherichia coli DH5[alpha] has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 14	Co-transport of human SLC11A2 substrates/drugs in the health condition		[80] , [83] , [4]
Regulating Factor	fhuC
Detailed Description	The protein fhuC of Escherichia coli AB2847 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 15	Sequestration of human SLC11A2 substrates/drugs in the health condition		[80] , [84] , [4]
Regulating Factor	fhuD
Detailed Description	The protein fhuD of Escherichia coli BL21(DE3) has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 16	Co-transport of human SLC11A2 substrates/drugs in the health condition		[85] , [4]
Regulating Factor	IroA , , , ,
Detailed Description	The protein IroA of Escherichia coli CFT073 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 17	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [86] , [3] , [4]
Regulating Factor	iroN
Detailed Description	The protein iroN of Escherichia coli O18:H7 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 18	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [11] , [12] , [87] , [88]
Regulating Factor	mntH
Detailed Description	The protein mntH of Escherichia coli EMG2 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Haemophilus
Haemophilus influenzae	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [89] , [4]
Regulating Factor	FhuCDB , ,
Detailed Description	The protein FhuCDB of Haemophilus influenzae R2866 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [9] , [39] , [90]
Regulating Factor	tbpA
Detailed Description	The protein tbpA of Haemophilus influenzae type b has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [9] , [39] , [90]
Regulating Factor	tbpB
Detailed Description	The protein tbpB of Haemophilus influenzae type b has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Klebsiella
Klebsiella pneumoniae	Microbe Info	Click to Show/Hide the Full List 6 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in pneumonia condition		[1] , [91] , [3] , [4]
Regulating Factor	Yersiniabactin
Studied Phenotype	Pneumonia [ICD11: CA40]
Studied Tissue	Lung
In Vivo Model	C57BL/6 mice
Detailed Description	The compound Yersiniabactin Secreted by Klebsiella pneumoniae ATCC 43816 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in lung adenocarcinoma condition		[1] , [92] , [3] , [4]
Regulating Factor	Salmochelin SX
Studied Phenotype	Lung cancer [ICD11: 2C25]
Studied Tissue	Lung
In Vitro Model	Human lung adenocarcinoma cells (A549)
Detailed Description	The compound Salmochelin SX Secreted by Klebsiella pneumoniae KP20 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [93] , [3] , [4]
Regulating Factor	Salmochelin SX
Studied Tissue	Lung
In Vivo Model	C57BL/6 mice
Detailed Description	The compound Salmochelin SX Secreted by Klebsiella pneumoniae KPPR1 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [93] , [3] , [4]
Regulating Factor	Yersiniabactin
Studied Tissue	Lung
In Vivo Model	C57BL/6 mice
Detailed Description	The compound Yersiniabactin Secreted by Klebsiella pneumoniae KPPR1 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [94] , [3] , [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Klebsiella pneumoniae 298/53 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 6	Co-transport of human SLC11A2 substrates/drugs in the health condition		[63] , [95] , [4]
Regulating Factor	feoC
Detailed Description	The protein feoc of Klebsiella pneumoniae has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Moraxella
Moraxella catarrhalis	Microbe Info	Click to Show/Hide the Full List 4 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[1] , [96] , [3] , [4]
Regulating Factor	lbpA
Detailed Description	The protein lbpa of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[1] , [96] , [3] , [4]
Regulating Factor	lbpB
Detailed Description	The protein lbpb of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[1] , [96] , [3] , [4]
Regulating Factor	tbpA
Detailed Description	The protein tbpa of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[1] , [96] , [3] , [4]
Regulating Factor	tbpB
Detailed Description	The protein tbpb of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Morganella
Morganella morganii	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-Oxoadipic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-Methyl-2-oxobutanoic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-Methyl-2-oxopentanoic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound Indole-3-pyruvic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound Phenylpyruvic acid Secreted by Morganella morganii SBK3 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Neisseria
Neisseria gonorrhoeae	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [98] , [3] , [4]
Regulating Factor	lbpA
Detailed Description	The protein lbpA of Neisseria gonorrhoeae FA19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [9] , [39] , [90]
Regulating Factor	tbpA
Detailed Description	The protein tbpa of Neisseria gonorrhoeae has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [9] , [39] , [90]
Regulating Factor	tbpB
Detailed Description	The protein tbpb of Neisseria gonorrhoeae has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Neisseria meningitidis	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [9] , [39] , [90]
Regulating Factor	tbp1
Detailed Description	The protein tbp1 of Neisseria meningitidis has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[3] , [4] , [9] , [39] , [90]
Regulating Factor	tbpB
Detailed Description	The protein tbpb of Neisseria meningitidis has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Proteus
Proteus mirabilis	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-Oxoadipic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-Methyl-2-oxobutanoic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-Methyl-2-oxopentanoic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound Indole-3-pyruvic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound Phenylpyruvic acid Secreted by Proteus mirabilis NM 12 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Proteus penneri	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-oxoadipic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-methyl-2-oxobutanoic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-methyl-2-oxopentanoic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound indole-3-pyruvic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound phenylpyruvic acid secreted by Proteus penneri has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Proteus vulgaris	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-Oxoadipic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-Methyl-2-oxobutanoic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-Methyl-2-oxopentanoic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound Indole-3-pyruvic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound Phenylpyruvic acid Secreted by Proteus vulgaris Ox 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Providencia
Providencia alcalifaciens	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-oxoadipic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-methyl-2-oxobutanoic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-methyl-2-oxopentanoic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound indole-3-pyruvic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound phenylpyruvic acid secreted by Providencia alcalifaciens 5487 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Providencia rustigianii	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-oxoadipic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-methyl-2-oxobutanoic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-methyl-2-oxopentanoic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound indole-3-pyruvic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound phenylpyruvic acid secreted by Providencia rustigianii 2 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Providencia stuartii	Microbe Info	Click to Show/Hide the Full List 5 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	2-Oxoadipic acid
Detailed Description	The compound 2-oxoadipic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	3-Methyl-2-oxobutanoic acid
Detailed Description	The compound 3-methyl-2-oxobutanoic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	4-Methyl-2-oxopentanoic acid
Detailed Description	The compound 4-methyl-2-oxopentanoic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Indole-3-pyruvic acid
Detailed Description	The compound indole-3-pyruvic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [97] , [3] , [4]
Regulating Factor	Phenylpyruvic acid
Detailed Description	The compound phenylpyruvic acid secreted by Providencia stuartii 19 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Pseudomonas
Pseudomonas aeruginosa	Microbe Info	Click to Show/Hide the Full List 6 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in cystic fibrosis condition		[99] , [3] , [4]
Regulating Factor	Pyochelin
Studied Phenotype	Cystic fibrosis [ICD11: CA25]
Studied Tissue	Lung
In Vivo Model	CD-1 mice
Detailed Description	The compound Pyochelin Secreted by Pseudomonas aeruginosa ATCC 15692 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in cystic fibrosis condition		[99] , [3] , [4]
Regulating Factor	Pyoverdine F-Iib
Studied Phenotype	Cystic fibrosis [ICD11: CA25]
Studied Tissue	Lung
In Vivo Model	CD-1 mice
Detailed Description	The compound Pyoverdine F-Iib Secreted by Pseudomonas aeruginosa ATCC 15692 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [100] , [3] , [4]
Regulating Factor	Pyochelin
Detailed Description	The compound Pyochelin Secreted by Pseudomonas aeruginosa PAO1 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [101] , [3] , [4]
Regulating Factor	Pyoverdin
Detailed Description	The compound Pyoverdin Secreted by Pseudomonas aeruginosa PAO1 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[102] , [3] , [4]
Regulating Factor	tonB
Detailed Description	The protein tonB of Pseudomonas aeruginosa K199 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 6	Sequestration of human SLC11A2 substrates/drugs in the health condition		[103] , [3] , [4]
Regulating Factor	TonB1
Detailed Description	The protein TonB1 of Pseudomonas aeruginosa K1040 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Rhizobium
Rhizobium leguminosarum	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [104]
Regulating Factor	SitABCD , ,
Detailed Description	The protein SitABCD of Rhizobium leguminosarum bv. viciae 3841 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Salmonella
Salmonella enterica	Microbe Info	Click to Show/Hide the Full List 17 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [105] , [3] , [4]
Regulating Factor	Enterobactin
Studied Tissue	Intestine
In Vivo Model	C3H/HeOuJ mice
Detailed Description	The compound Enterobactin Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [105] , [3] , [4]
Regulating Factor	Salmochelin SX
Studied Tissue	Intestine
In Vivo Model	C3H/HeOuJ mice
Detailed Description	The compound Salmochelin SX Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [106] , [3] , [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 4	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [107] , [4]
Regulating Factor	Ferrioxamine B
Detailed Description	The compound Ferrioxamine B Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 5	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [107] , [4]
Regulating Factor	Ferrioxamine E
Detailed Description	The compound Ferrioxamine E Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 6	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [107] , [4]
Regulating Factor	Ferrioxamine G1
Detailed Description	The compound Ferrioxamine G1 Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 7	Sequestration of human SLC11A2 substrates/drugs in the health condition		[23] , [108] , [3] , [4]
Regulating Factor	Salmochelin SX
Detailed Description	The compound Salmochelin SX Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. LT2 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 8	Co-transport of human SLC11A2 substrates/drugs in the health condition		[15] , [105] , [3] , [4]
Regulating Factor	fepD
Studied Tissue	Intestine
In Vivo Model	C3H/HeOuJ mice
Detailed Description	The protein fepD of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 9	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [33]
Regulating Factor	SitABCD , , ,
Studied Tissue	Liver
In Vivo Model	C57BL/6 mice
Detailed Description	The protein SitABCD of Salmonella enterica subsp. enterica serovar Typhimurium IR715 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 10	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [109]
Regulating Factor	SitABCD , , ,
Studied Tissue	Blood
In Vivo Model	129/SvJ mice
Detailed Description	The protein SitABCD of Salmonella enterica subsp. enterica serovar Typhimurium has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 11	Co-transport of human SLC11A2 substrates/drugs in the health condition		[63] , [110] , [4]
Regulating Factor	feoA
Detailed Description	The protein feoA of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 12	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [111] , [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 13	Sequestration of human SLC11A2 substrates/drugs in the health condition		[63] , [110] , [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 14	Co-transport of human SLC11A2 substrates/drugs in the health condition		[63] , [110] , [4]
Regulating Factor	feoC
Detailed Description	The protein feoC of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 15	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [87]
Regulating Factor	SitABCD , , ,
Detailed Description	The protein SitABCD of Salmonella enterica subsp. enterica serovar Typhimurium MM1255 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 16	Co-transport of human SLC11A2 substrates/drugs in the health condition		[15] , [105] , [4]
Regulating Factor	SitABCD , , ,
Detailed Description	The protein SitABCD of Salmonella enterica subsp. enterica serovar Typhimurium JF2043 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 17	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [111] , [3] , [4]
Regulating Factor	tonB
Detailed Description	The protein tonB of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Serratia
Serratia marcescens	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[63] , [64] , [112] , [4]
Regulating Factor	sfuA
Detailed Description	The protein sfua of Serratia marcescens has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Co-transport of human SLC11A2 substrates/drugs in the health condition		[63] , [64] , [112] , [4]
Regulating Factor	sfuB
Detailed Description	The protein sfub of Serratia marcescens has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 3	Co-transport of human SLC11A2 substrates/drugs in the health condition		[63] , [64] , [112] , [4]
Regulating Factor	sfuC
Detailed Description	The protein sfuc of Serratia marcescens has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Shigella
Shigella flexneri	Microbe Info	Click to Show/Hide the Full List 6 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [113] , [4]
Regulating Factor	fec
Detailed Description	The protein fec of Shigella flexneri 2a has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [114] , [4]
Regulating Factor	feoB
Detailed Description	The protein feoB of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 3	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [114] , [4]
Regulating Factor	sitA
Detailed Description	The protein sitA of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 4	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [6] , [7] , [114]
Regulating Factor	sitA
Detailed Description	The protein sitA of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 5	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [114] , [4]
Regulating Factor	SitABCD , , ,
Detailed Description	The protein SitABCD of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 6	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [114]
Regulating Factor	SitABCD , , ,
Detailed Description	The protein SitABCD of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Shigella sonnei	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[15] , [94] , [3] , [4]
Regulating Factor	Enterobactin
Detailed Description	The compound Enterobactin Secreted by Shigella sonnei 43-GG9 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Genus: Sinorhizobium
Sinorhizobium meliloti	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [115]
Regulating Factor	MntABC , ,
Detailed Description	The protein mntabc of Sinorhizobium meliloti 242 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Vibrio
Vibrio anguillarum	Microbe Info	Click to Show/Hide the Full List 3 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [116] , [3] , [4]
Regulating Factor	Anguibactin
Detailed Description	The compound anguibactin secreted by Vibrio anguillarum 775 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Co-transport of human SLC11A2 substrates/drugs in the health condition		[13] , [116] , [4]
Regulating Factor	fatA
Detailed Description	The protein fata of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 3	Co-transport of human SLC11A2 substrates/drugs in the health condition		[13] , [116] , [4]
Regulating Factor	fatB
Detailed Description	The protein fatb of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Vibrio cholerae	Microbe Info	Click to Show/Hide the Full List 6 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [117] , [3] , [4]
Regulating Factor	Vibriobactin
Detailed Description	The compound Vibriobactin Secreted by Vibrio cholerae Lou15 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [118] , [3] , [4]
Regulating Factor	Vibriobactin
Detailed Description	The compound Vibriobactin Secreted by Vibrio cholerae MBG14 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 3	Co-transport of human SLC11A2 substrates/drugs in cholera condition		[6] , [7] , [119]
Regulating Factor	ZnuABC , ,
Studied Phenotype	Cholera [ICD11: 1A00]
Studied Tissue	Small intestine
In Vivo Model	CD-1 mice
Detailed Description	The protein ZnuABC of Vibrio cholerae C6706 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 4	Co-transport of human SLC11A2 substrates/drugs in cholera condition		[6] , [7] , [119]
Regulating Factor	ZrgABCDE , , , ,
Studied Phenotype	Cholera [ICD11: 1A00]
Studied Tissue	Small intestine
In Vivo Model	CD-1 mice
Detailed Description	The protein ZrgABCDE of Vibrio cholerae C6706 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 5	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [120] , [4]
Regulating Factor	Fbp
Detailed Description	The protein Fbp of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 6	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [120] , [4]
Regulating Factor	feo
Detailed Description	The protein feo of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Genus: Yersinia
Yersinia enterocolitica	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [121] , [3] , [4]
Regulating Factor	Yersiniabactin
Detailed Description	The compound Yersiniabactin Secreted by Yersinia enterocolitica WA-C has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [121] , [4]
Regulating Factor	fyuA
Detailed Description	The protein fyuA of Yersinia enterocolitica WA-C has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Yersinia pestis	Microbe Info	Click to Show/Hide the Full List 11 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[13] , [122] , [3] , [4]
Regulating Factor	Yersiniabactin
Detailed Description	The compound Yersiniabactin Secreted by Yersinia pestis Yreka F1+VW+P1+P+ has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Co-transport of human SLC11A2 substrates/drugs in pneumonic plague condition		[123] , [4]
Regulating Factor	feo
Studied Phenotype	Pneumonic plague [ICD11: 1B93.2]
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein feo of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 3	Co-transport of human SLC11A2 substrates/drugs in pneumonic plague condition		[5] , [6] , [7] , [123]
Regulating Factor	yfeA
Studied Phenotype	Pneumonic plague [ICD11: 1B93.2]
Studied Tissue	Nose
In Vivo Model	Swiss Webster mice
Detailed Description	The protein yfeA of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 4	Co-transport of human SLC11A2 substrates/drugs in pneumonic plague condition		[5] , [6] , [7] , [124]
Regulating Factor	YfeABCD , , ,
Studied Phenotype	Pneumonic plague [ICD11: 1B93.2]
Studied Tissue	Nose
In Vivo Model	Swiss Webster mice
Detailed Description	The protein yfeabcd of Yersinia pestis has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 5	Co-transport of human SLC11A2 substrates/drugs in pneumonic plague condition		[5] , [6] , [7] , [124]
Regulating Factor	YfeABCD , , ,
Studied Phenotype	Pneumonic plague [ICD11: 1B93.2]
Studied Tissue	Nose
In Vivo Model	Swiss Webster mice
Detailed Description	The protein YfeABCD of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 6	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [125] , [3] , [4]
Regulating Factor	irp2
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein irp2 of Yersinia pestis KIM5 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 7	Sequestration of human SLC11A2 substrates/drugs in the health condition		[20] , [125] , [4]
Regulating Factor	psn
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein psn of Yersinia pestis KIM5 has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 8	Co-transport of human SLC11A2 substrates/drugs in the health condition		[20] , [126] , [4]
Regulating Factor	YfeAB ,
Studied Tissue	Blood
In Vivo Model	Swiss Webster mice
Detailed Description	The protein YfeAB of Yersinia pestis KIM5 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 9	Co-transport of human SLC11A2 substrates/drugs in the health condition		[123] , [4]
Regulating Factor	YfeABCD , , ,
Studied Tissue	Lung
In Vivo Model	Swiss Webster mice
Detailed Description	The protein YfeABCD of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 10	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [126] , [4]
Regulating Factor	YfeABCD , , ,
Detailed Description	The protein YfeABCD of Yersinia pestis KIM5-2031.11+ has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 11	Co-transport of human SLC11A2 substrates/drugs in the health condition		[5] , [6] , [7] , [126]
Regulating Factor	YfeABCD , , ,
Detailed Description	The protein YfeABCD of Yersinia pestis KIM5-2031.11+ has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Yersinia pseudotuberculosis	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[127] , [4]
Regulating Factor	tssS
Detailed Description	The protein tssS of Yersinia pseudotuberculosis YPIII has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Bacteria: Spirochaetota
Genus: Treponema
Treponema pallidum	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[128] , [4]
Regulating Factor	troA
Detailed Description	The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Microbe Influence 2	Sequestration of human SLC11A2 substrates/drugs in the health condition		[128] , [3] , [4]
Regulating Factor	troA
Detailed Description	The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Fungi: Ascomycota
Genus: Candida
Candida albicans	Microbe Info	Click to Show/Hide the Full List 2 Microbe Influence Related to This Species
Microbe Influence 1	Co-transport of human SLC11A2 substrates/drugs in the health condition		[15] , [93] , [3] , [4]
Regulating Factor	Sit1p
Studied Tissue	Blood
In Vivo Model	BALB/c mice
Detailed Description	The protein Sit1p of Candida albicans CAF2-1 has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Microbe Influence 2	Co-transport of human SLC11A2 substrates/drugs in the health condition		[15] , [129] , [4]
Regulating Factor	CaFTR1
Detailed Description	The protein caftr1 of Candida albicans has been reported to transport similar substrates/drugs of SLC11A2, which affects the distribution of its substrate/drug in vivo.
Fungi: Mucoromycota
Genus: Rhizopus
Rhizopus microsporus	Microbe Info	Click to Show/Hide the Full List 1 Microbe Influence Related to This Species
Microbe Influence 1	Sequestration of human SLC11A2 substrates/drugs in the health condition		[1] , [130] , [3] , [4]
Regulating Factor	Rhizoferrin
Detailed Description	The compound rhizoferrin secreted by Rhizopus microsporus has been reported to sequester the substrate/drug of SLC11A2, which may affects its substrate/drug distribution in the body.
Bacteria: Host unspecified microbiota
Genus: Unknown microbiota
Host unspecified microbiota		Click to Show/Hide the Full List 6 Microbe Influence Related to This Species
Microbe Influence 1	Up regulating of SLC11A2 expression in anemia condition		[131]
Regulating Factor	Short-chain fatty acid (Acetate)
Studied Phenotype	Anemia [ICD11: 3A01.30]
Studied Tissue	Colon
In Vivo Model	Yorkshire-Hampshire-Landrace hybrid pigs
Detailed Description	The metabolite short-chain fatty acid (acetate) generated from the metabolism of dietary inulin by the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC11A2.
Microbe Influence 2	Up regulating of SLC11A2 expression in anemia condition		[131]
Regulating Factor	Short-chain fatty acid (Acetate)
Studied Phenotype	Anemia [ICD11: 3A01.30]
Studied Tissue	Duodenum
In Vivo Model	Yorkshire-Hampshire-Landrace hybrid pigs
Detailed Description	The metabolite short-chain fatty acid (acetate) generated from the metabolism of dietary inulin by the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC11A2.
Microbe Influence 3	Up regulating of SLC11A2 expression in anemia condition		[131]
Regulating Factor	Short-chain fatty acid (Butyrate)
Studied Phenotype	Anemia [ICD11: 3A01.30]
Studied Tissue	Colon
In Vivo Model	Yorkshire-Hampshire-Landrace hybrid pigs
Detailed Description	The metabolite short-chain fatty acid (butyrate) generated from the metabolism of dietary inulin by the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC11A2.
Microbe Influence 4	Up regulating of SLC11A2 expression in anemia condition		[131]
Regulating Factor	Short-chain fatty acid (Butyrate)
Studied Phenotype	Anemia [ICD11: 3A01.30]
Studied Tissue	Duodenum
In Vivo Model	Yorkshire-Hampshire-Landrace hybrid pigs
Detailed Description	The metabolite short-chain fatty acid (butyrate) generated from the metabolism of dietary inulin by the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC11A2.
Microbe Influence 5	Up regulating of SLC11A2 expression in anemia condition		[131]
Regulating Factor	Short-chain fatty acid (Propionate)
Studied Phenotype	Anemia [ICD11: 3A01.30]
Studied Tissue	Colon
In Vivo Model	Yorkshire-Hampshire-Landrace hybrid pigs
Detailed Description	The metabolite short-chain fatty acid (propionate) generated from the metabolism of dietary inulin by the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC11A2.
Microbe Influence 6	Up regulating of SLC11A2 expression in anemia condition		[131]
Regulating Factor	Short-chain fatty acid (Propionate)
Studied Phenotype	Anemia [ICD11: 3A01.30]
Studied Tissue	Duodenum
In Vivo Model	Yorkshire-Hampshire-Landrace hybrid pigs
Detailed Description	The metabolite short-chain fatty acid (propionate) generated from the metabolism of dietary inulin by the host unspecified microbiota has been reported to increase the expression of the drug transporter SLC11A2.

References
1	The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat Rev Microbiol. 2017 Oct 12;15(11):675-687.
2	Purification and structural characterization of siderophore (corynebactin) from Corynebacterium diphtheriae. PLoS One. 2012;7(4):e34591.
3	Iron, copper, zinc, and manganese transport and regulation in pathogenic Enterobacteria: correlations between strains, site of infection and the relative importance of the different metal transport systems for virulence. Front Cell Infect Microbiol. 2013 Dec 5;3:90.
4	Iron and manganese transport in mammalian systems. Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118890.
5	Manganese homeostasis and utilization in pathogenic bacteria. Mol Microbiol. 2015 Jul;97(2):216-28.
6	Manganese transport and the role of manganese in virulence. Annu Rev Microbiol. 2006;60:187-209.
7	A manganese transporter, BB0219 (BmtA), is required for virulence by the Lyme disease spirochete, Borrelia burgdorferi. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3449-54.
8	Analysis of a DtxR-like metalloregulatory protein, MntR, from Corynebacterium diphtheriae that controls expression of an ABC metal transporter by an Mn(2+)-dependent mechanism. J Bacteriol. 2002 Dec;184(24):6882-92.
9	Mycobacterium tuberculosis acquires iron by cell-surface sequestration and internalization of human holo-transferrin. Nat Commun. 2014 Aug 28;5:4730.
10	Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system. J Immunol. 2005 Feb 1;174(3):1491-500.
11	Human iron transporters. Genes Nutr. 2011 Feb;6(1):45-54.
12	Iron transport machinery of human cells: players and their interactions. Curr Top Membr. 2012;69:67-93.
13	Iron metabolism in pathogenic bacteria. Annu Rev Microbiol. 2000;54:881-941.
14	Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med. 1996 Apr 1;183(4):1527-32.
15	Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis. Front Cell Infect Microbiol. 2014 Jan 24;4:2.
16	Mycobactin-mediated iron acquisition within macrophages. Nat Chem Biol. 2005 Aug;1(3):149-53.
17	The Mycobacterium tuberculosis high-affinity iron importer, IrtA, contains an FAD-binding domain. J Bacteriol. 2010 Feb;192(3):861-9.
18	Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family. J Exp Med. 1999 Sep 6;190(5):717-24.
19	Iron uptake processes in Mycobacterium vaccae R877R, a mycobacterium lacking mycobactin. J Gen Microbiol. 1986 Mar;132(3):845-52.
20	Sequestration and scavenging of iron in infection. Infect Immun. 2013 Oct;81(10):3503-14.
21	IlsA, a unique surface protein of Bacillus cereus required for iron acquisition from heme, hemoglobin and ferritin. PLoS Pathog. 2009 Nov;5(11):e1000675.
22	Siderophores of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Biochem Biophys Res Commun. 2006 Sep 15;348(1):320-5.
23	The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 2010 Aug 12;6(8):e1000949.
24	Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18499-503.
25	The solute-binding component of a putative Mn(II) ABC transporter (MntA) is a novel Bacillus anthracis virulence determinant. Mol Microbiol. 2005 Oct;58(2):533-51.
26	Manganese-dependent regulation of the endocarditis-associated virulence factor EfaA of Enterococcus faecalis. J Med Microbiol. 2003 Feb;52(Pt 2):113-119.
27	Cloning, expression, and characterization of cadmium and manganese uptake genes from Lactobacillus plantarum. Appl Environ Microbiol. 1999 Nov;65(11):4746-52.
28	Metallobiology of Lactobacillaceae in the gut microbiome. J Inorg Biochem. 2023 Jan;238:112023.
29	Microbial Metabolite Signaling Is Required for Systemic Iron Homeostasis. Cell Metab. 2020 Jan 7;31(1):115-130.e6.
30	Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins. Infect Immun. 1997 May;65(5):1944-8.
31	Identification and characterization of the Staphylococcus aureus gene cluster coding for staphyloferrin A. Biochemistry. 2009 Feb 10;48(5):1025-35.
32	Biosynthesis of a broad-spectrum nicotianamine-like metallophore in Staphylococcus aureus. Science. 2016 May 27;352(6289):1105-9.
33	MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect Immun. 2013 Sep;81(9):3395-405.
34	Siderophore-mediated iron acquisition in the staphylococci. J Inorg Biochem. 2010 Mar;104(3):282-8.
35	FhuD1, a ferric hydroxamate-binding lipoprotein in Staphylococcus aureus: a case of gene duplication and lateral transfer. J Biol Chem. 2004 Dec 17;279(51):53152-9.
36	The role of FhuD2 in iron(III)-hydroxamate transport in Staphylococcus aureus. Demonstration that FhuD2 binds iron(III)-hydroxamates but with minimal conformational change and implication of mutations on transport. J Biol Chem. 2003 Dec 12;278(50):49890-900.
37	Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus. Mol Microbiol. 2009 May;72(4):947-63.
38	Transferrin binding in Staphylococcus aureus: involvement of a cell wall-anchored protein. Mol Microbiol. 2002 Mar;43(6):1603-14.
39	The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect Immun. 1999 Mar;67(3):1086-92.
40	Staphylococci express a receptor for human transferrin: identification of a 42-kilodalton cell wall transferrin-binding protein. Infect Immun. 1994 Sep;62(9):3850-8.
41	MntR modulates expression of the PerR regulon and superoxide resistance in Staphylococcus aureus through control of manganese uptake. Mol Microbiol. 2002 Jun;44(5):1269-86.
42	Involvement of SirABC in iron-siderophore import in Staphylococcus aureus. J Bacteriol. 2004 Dec;186(24):8356-62.
43	Molecular cloning and analysis of a putative siderophore ABC transporter from Staphylococcus aureus. Infect Immun. 2000 Nov;68(11):6281-8.
44	Crystal structure of a SLC11 (NRAMP) transporter reveals the basis for transition-metal ion transport. Nat Struct Mol Biol. 2014 Nov;21(11):990-6.
45	Evidence for siderophore-dependent iron acquisition in group B streptococcus. Mol Microbiol. 2006 Jan;59(2):707-21.
46	A new family of high-affinity ABC manganese and zinc permeases. Res Microbiol. 2001 Apr-May;152(3-4):231-43.
47	Identification of lipoprotein homologues of pneumococcal PsaA in the equine pathogens Streptococcus equi and Streptococcus zooepidemicus. Infect Immun. 2000 Oct;68(10):6048-51.
48	Involvement of the adc operon and manganese homeostasis in Streptococcus gordonii biofilm formation. J Bacteriol. 2003 May;185(9):2887-900.
49	The adhesion-associated sca operon in Streptococcus gordonii encodes an inducible high-affinity ABC transporter for Mn2+ uptake. J Bacteriol. 1998 Jan;180(2):290-5.
50	The sloABCR operon of Streptococcus mutans encodes an Mn and Fe transport system required for endocarditis virulence and its Mn-dependent repressor. J Bacteriol. 2003 Oct;185(20):5967-75.
51	The divergently transcribed Streptococcus parasanguis virulence-associated fimA operon encoding an Mn(2+)-responsive metal transporter and pepO encoding a zinc metallopeptidase are not coordinately regulated. Infect Immun. 2002 Oct;70(10):5706-14.
52	Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol Microbiol. 1997 Aug;25(4):727-39.
53	Molecular analysis of the psa permease complex of Streptococcus pneumoniae. Mol Microbiol. 2004 Aug;53(3):889-901.
54	MtsABC is important for manganese and iron transport, oxidative stress resistance, and virulence of Streptococcus pyogenes. Infect Immun. 2003 May;71(5):2656-64.
55	TroA of Streptococcus suis is required for manganese acquisition and full virulence. J Bacteriol. 2011 Oct;193(19):5073-80.
56	Metal homeostasis in pathogenic Epsilonproteobacteria: mechanisms of acquisition, efflux, and regulation. Metallomics. 2021 Jan 16;13(1):mfaa002.
57	Nutrient acquisition and metabolism by Campylobacter jejuni. Front Cell Infect Microbiol. 2012 Feb 7;2:5.
58	Identification and characterization of a new ferric enterobactin receptor, CfrB, in Campylobacter. J Bacteriol. 2010 Sep;192(17):4425-35.
59	Iron acquisition and regulation in Campylobacter jejuni. J Bacteriol. 2004 Jul;186(14):4714-29.
60	Utilization of lactoferrin-bound and transferrin-bound iron by Campylobacter jejuni. J Bacteriol. 2008 Mar;190(6):1900-11.
61	Major role for FeoB in Campylobacter jejuni ferrous iron acquisition, gut colonization, and intracellular survival. Infect Immun. 2006 Oct;74(10):5433-44.
62	Structure and function of P19, a high-affinity iron transporter of the human pathogen Campylobacter jejuni. J Mol Biol. 2010 Aug 27;401(4):590-604.
63	Bacterial ferrous iron transport: the Feo system. FEMS Microbiol Rev. 2016 Mar;40(2):273-98.
64	Iron-binding activity of FutA1 subunit of an ABC-type iron transporter in the cyanobacterium Synechocystis sp. Strain PCC 6803. Plant Cell Physiol. 2001 Aug;42(8):823-7.
65	Genes essential to iron transport in the cyanobacterium Synechocystis sp. strain PCC 6803. J Bacteriol. 2001 May;183(9):2779-84.
66	Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity. Infect Immun. 2019 Mar 25;87(4):e00755-18.
67	Purification, spectroscopic analysis and biological activity of the macrocyclic dihydroxamate siderophore alcaligin produced by Bordetella pertussis and Bordetella bronchiseptica. Biometals. 1996 Apr;9(2):191-203.
68	Bacterial outer membrane channel for divalent metal ion acquisition. Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15390-5.
69	Cepabactin from Pseudomonas cepacia, a new type of siderophore. J Gen Microbiol. 1989 Jun;135(6):1479-87.
70	Ornibactins--a new family of siderophores from Pseudomonas. Biometals. 1993 Summer;6(2):93-100.
71	Isolation of a novel siderophore from Pseudomonas cepacia. J Med Microbiol. 1992 Mar;36(3):184-9.
72	Relative availability of transferrin-bound iron and cell-derived iron to aerobactin-producing and enterochelin-producing strains of Escherichia coli and to other microorganisms. Infect Immun. 1991 Sep;59(9):3185-90.
73	The alternative role of enterobactin as an oxidative stress protector allows Escherichia coli colony development. PLoS One. 2014 Jan 2;9(1):e84734.
74	Production of enterochelin by Escherichia coli 0111. Biochim Biophys Acta. 1977 Apr 27;497(2):548-57.
75	The structure of enterochelin and related 2,3-dihydroxy-N-benzoylserine conjugates from Escherichia coli. Biochim Biophys Acta. 1970 Aug 14;215(2):393-402.
76	A new ferrous iron-uptake transporter, EfeU (YcdN), from Escherichia coli. Mol Microbiol. 2006 Oct;62(1):120-31.
77	EfeUOB (YcdNOB) is a tripartite, acid-induced and CpxAR-regulated, low-pH Fe2+ transporter that is cryptic in Escherichia coli K-12 but functional in E. coli O157:H7. Mol Microbiol. 2007 Aug;65(4):857-75.
78	Structural basis of gating by the outer membrane transporter FecA. Science. 2002 Mar 1;295(5560):1715-9.
79	Characterization of the ferrous iron uptake system of Escherichia coli. J Bacteriol. 1993 Oct;175(19):6212-9.
80	Iron uptake mechanisms and their regulation in pathogenic bacteria. Int J Med Microbiol. 2001 May;291(2):67-79.
81	Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science. 1998 Dec 18;282(5397):2215-20.
82	Transmembrane topology of the two FhuB domains representing the hydrophobic components of bacterial ABC transporters involved in the uptake of siderophores, haem and vitamin B12. Microbiology (Reading). 1998 Oct;144 ( Pt 10):2759-2769.
83	Iron(III) hydroxamate transport in Escherichia coli K-12: FhuB-mediated membrane association of the FhuC protein and negative complementation of fhuC mutants. J Bacteriol. 1992 Apr;174(7):2305-11.
84	The structure of the ferric siderophore binding protein FhuD complexed with gallichrome. Nat Struct Biol. 2000 Apr;7(4):287-91.
85	The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16502-7.
86	The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis. Infect Immun. 2004 Feb;72(2):1216-20.
87	The NRAMP proteins of Salmonella typhimurium and Escherichia coli are selective manganese transporters involved in the response to reactive oxygen. Mol Microbiol. 2000 Jun;36(5):1085-100.
88	Identification of the Escherichia coli K-12 Nramp orthologue (MntH) as a selective divalent metal ion transporter. Mol Microbiol. 2000 Mar;35(5):1065-78.
89	Identification of a siderophore utilization locus in nontypeable Haemophilus influenzae. BMC Microbiol. 2010 Apr 15;10:113.
90	Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol Microbiol. 1994 Dec;14(5):843-50.
91	Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun. 2011 Aug;79(8):3309-16.
92	Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1alpha and proinflammatory cytokine secretion in cultured respiratory epithelial cells. Infect Immun. 2014 Sep;82(9):3826-36.
93	The siderophore iron transporter of Candida albicans (Sit1p/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion. Infect Immun. 2002 Sep;70(9):5246-55.
94	Siderophore synthesis in Klebsiella pneumoniae and Shigella sonnei during iron deficiency. J Bacteriol. 1979 Dec;140(3):1129-32.
95	NMR structure note: the ferrous iron transport protein C (FeoC) from Klebsiella pneumoniae. J Biomol NMR. 2012 Jun;53(2):161-5.
96	Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect. 2000 Apr;2(5):547-59.
97	Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases. J Bacteriol. 1993 May;175(9):2727-33.
98	Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect Immun. 1995 Aug;63(8):2958-67.
99	Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection. Infect Immun. 2016 Jul 21;84(8):2324-2335.
100	Pyochelin: novel structure of an iron-chelating growth promoter for Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4256-60.
101	Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin. Infect Immun. 1985 Jul;49(1):132-40.
102	The Pseudomonas aeruginosa tonB gene encodes a novel TonB protein. Microbiology (Reading). 1996 Jun;142 ( Pt 6):1449-1458.
103	Mutational analysis of the TonB1 energy coupler of Pseudomonas aeruginosa. J Bacteriol. 2002 Mar;184(6):1503-13.
104	The Fur-like protein Mur of Rhizobium leguminosarum is a Mn(2+)-responsive transcriptional regulator. Microbiology (Reading). 2004 May;150(Pt 5):1447-1456.
105	Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol. 2008 Mar;67(5):971-83.
106	Enterobactin, an iron transport compound from Salmonella typhimurium. Biochem Biophys Res Commun. 1970 Mar 12;38(5):989-92.
107	Ferrioxamine-mediated Iron(III) utilization by Salmonella enterica. Appl Environ Microbiol. 1999 Apr;65(4):1610-8.
108	Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3677-82.
109	Acquisition of Mn(II) in addition to Fe(II) is required for full virulence of Salmonella enterica serovar Typhimurium. Infect Immun. 2002 Nov;70(11):6032-42.
110	Lon-mediated proteolysis of the FeoC protein prevents Salmonella enterica from accumulating the Fe(II) transporter FeoB under high-oxygen conditions. J Bacteriol. 2015 Jan 1;197(1):92-8.
111	Contribution of TonB- and Feo-mediated iron uptake to growth of Salmonella typhimurium in the mouse. Infect Immun. 1996 Nov;64(11):4549-56.
112	Nucleotide sequences of the sfuA, sfuB, and sfuC genes of Serratia marcescens suggest a periplasmic-binding-protein-dependent iron transport mechanism. J Bacteriol. 1990 Feb;172(2):572-8.
113	Ferric dicitrate transport system (Fec) of Shigella flexneri 2a YSH6000 is encoded on a novel pathogenicity island carrying multiple antibiotic resistance genes. Infect Immun. 2001 Oct;69(10):6012-21.
114	Contribution of the Shigella flexneri Sit, Iuc, and Feo iron acquisition systems to iron acquisition in vitro and in cultured cells. Infect Immun. 2003 Apr;71(4):1919-28.
115	Fur is involved in manganese-dependent regulation of mntA (sitA) expression in Sinorhizobium meliloti. Appl Environ Microbiol. 2004 Jul;70(7):4349-55.
116	The AngR protein and the siderophore anguibactin positively regulate the expression of iron-transport genes in Vibrio anguillarum. Mol Microbiol. 1996 Oct;22(1):127-34.
117	Cloning of a Vibrio cholerae vibriobactin gene cluster: identification of genes required for early steps in siderophore biosynthesis. J Bacteriol. 1997 Nov;179(22):7055-62.
118	Cloning, sequencing, and transcriptional regulation of viuA, the gene encoding the ferric vibriobactin receptor of Vibrio cholerae. J Bacteriol. 1992 Jun;174(11):3729-38.
119	Dual Zinc Transporter Systems in Vibrio cholerae Promote Competitive Advantages over Gut Microbiome. Infect Immun. 2015 Oct;83(10):3902-8.
120	Characterization of ferric and ferrous iron transport systems in Vibrio cholerae. J Bacteriol. 2006 Sep;188(18):6515-23.
121	Purification of yersiniabactin: a siderophore and possible virulence factor of Yersinia enterocolitica. J Gen Microbiol. 1993 Sep;139(9):2159-65.
122	Siderochrome production by Yersinia pestis and its relation to virulence. Infect Immun. 1975 Nov;12(5):1211-3.
123	The Yfe and Feo transporters are involved in microaerobic growth and virulence of Yersinia pestis in bubonic plague. Infect Immun. 2012 Nov;80(11):3880-91.
124	Manganese transporters Yfe and MntH are Fur-regulated and important for the virulence of Yersinia pestis. Microbiology (Reading). 2012 Mar;158(Pt 3):804-815.
125	The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect Immun. 2010 May;78(5):2045-52.
126	The Yfe system of Yersinia pestis transports iron and manganese and is required for full virulence of plague. Mol Microbiol. 1999 Apr;32(2):403-14.
127	T6SS translocates a micropeptide to suppress STING-mediated innate immunity by sequestering manganese. Proc Natl Acad Sci U S A. 2021 Oct 19;118(42):e2103526118.
128	The general transition metal (Tro) and Zn2+ (Znu) transporters in Treponema pallidum: analysis of metal specificities and expression profiles. Mol Microbiol. 2007 Jul;65(1):137-52.
129	A high-affinity iron permease essential for Candida albicans virulence. Science. 2000 May 12;288(5468):1062-4.
130	Rhizoferrin: a complexone type siderophore of the Mucorales and entomophthorales (Zygomycetes). FEMS Microbiol Lett. 1992 Jul 1;73(1-2):37-41.
131	Dietary inulin affects the expression of intestinal enterocyte iron transporters, receptors and storage protein and alters the microbiota in the pig intestine. Br J Nutr. 2008 Mar;99(3):472-80.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Microbiota Influence

Visitor Map

Correspondence